Guardian Pharmacy Services, Inc. (GRDN)

GRDN Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,282	1,228	1,046	908.91	792.07	735.96
Revenue Growth (YoY)	19.55%	17.42%	15.10%	14.75%	7.63%	5.39%
Cost of Revenue	1,029	984.04	837.88	723.04	630.81	588.96
Gross Profit	253.62	244.37	208.31	185.87	161.27	147
Selling, General & Admin	309.23	302.85	143.91	133.88	118.09	102.54
Operating Expenses	309.23	302.85	143.91	133.88	131.12	114.05
Operating Income	-55.61	-58.48	64.4	51.99	30.15	32.95
Interest Expense	-2.68	-3.28	-2.86	-1.93	-1.64	-2.16
Other Non Operating Income (Expenses)	0.07	-0.28	-0.37	-0.4	-0.19	-0.25
EBT Excluding Unusual Items	-58.23	-62.04	61.17	49.66	28.33	30.54
Merger & Restructuring Charges	-	-	-	-	-	-0.25
Other Unusual Items	0.55	-4.44	-23.45	-	-	-0.64
Pretax Income	-57.68	-66.48	37.72	49.66	28.33	29.66
Income Tax Expense	8.39	4.56	-	-	-	-
Earnings From Continuing Operations	-66.07	-71.03	37.72	49.66	28.33	29.66
Minority Interest in Earnings	-11.77	-16.25	-13.82	-14.24	-12.01	-9.72
Net Income	-77.84	-87.29	23.9	35.42	16.31	19.94
Preferred Dividends & Other Adjustments	22.76	22.76	23.9	-	-	-
Net Income to Common	-100.6	-110.05	-	35.42	16.31	19.94
Net Income Growth	-	-	-32.52%	117.12%	-18.20%	-8.29%
Shares Outstanding (Basic)	63	62	-	-	-	-
Shares Outstanding (Diluted)	63	62	-	-	-	-
EPS (Basic)	-1.59	-1.77	-	-	-	-
EPS (Diluted)	-1.59	-1.77	-	-	-	-
Free Cash Flow	48.37	41.59	56.26	31.75	49.22	44.27
Free Cash Flow Per Share	0.76	0.67	-	-	-	-
Gross Margin	19.78%	19.89%	19.91%	20.45%	20.36%	19.97%
Operating Margin	-4.34%	-4.76%	6.16%	5.72%	3.81%	4.48%
Profit Margin	-7.85%	-8.96%	-	3.90%	2.06%	2.71%
Free Cash Flow Margin	3.77%	3.39%	5.38%	3.49%	6.21%	6.02%
EBITDA	-35.32	-38.71	82.63	68.55	46.68	50.2
EBITDA Margin	-2.75%	-3.15%	7.90%	7.54%	5.89%	6.82%
D&A For EBITDA	20.29	19.77	18.23	16.56	16.53	17.26
EBIT	-55.61	-58.48	64.4	51.99	30.15	32.95
EBIT Margin	-4.34%	-4.76%	6.16%	5.72%	3.81%	4.48%

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q